Filip Garbicz

Dr. Filip Garbicz is a Postdoctoral Research Fellow at Dana-Farber Cancer Institute, Research Fellow in Pathology at Harvard Medical School, and Research Affiliate at the Broad Institute of MIT and Harvard. He holds an M.D. from the Medical University of Warsaw and is completing his Ph.D. at the same institution with research on kinase signaling in blood cancers.

His research employs single-cell RNA sequencing, epigenomics, and proteomics to model human cancer in genetically engineered mice, focusing on cancer origins, progression, and therapeutic translation.

He has lectured in Immunology, Histology, and Embryology at Polish medical schools and enjoys cycling, tennis, and wildlife observation outside the lab.